Binding Interactions of Antagonists with 5-Hydroxytryptamine3A Receptor Models

Journal of Receptors and Signal Transduction

Volumn 23, Issue 2-3, 2003, Pages 255-270

  Maksay, Gábor ^a   Bikádi, Zsolt ^a   Simonyi, Miklós ^a  

^a CHEMICAL RESEARCH CENTER   (Hungary)

Author keywords

5 HT3 receptor; Docking of antagonists; Homology modeling; Pharmacophore model; Species differences; Tropisetron; Tubocurarine

Indexed keywords

ACETYLCHOLINE; CARBONYL DERIVATIVE; DOLASETRON MESILATE; GRANISETRON; ONDANSETRON; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; SEROTONIN 3A RECEPTOR; TROPISETRON; TUBOCURARINE CHLORIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG BINDING SITE; DRUG RECEPTOR BINDING; GUINEA PIG; HUMAN; HYDROGEN BOND; LIGAND BINDING; MOUSE; NONHUMAN; PHARMACOPHORE; SEQUENCE HOMOLOGY; SPECIES DIFFERENCE;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CARRIER PROTEINS; GUINEA PIGS; HUMANS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; PROTEIN CONFORMATION; PROTEIN SUBUNITS; RECEPTORS, SEROTONIN, 5-HT3; SEQUENCE ALIGNMENT; SEROTONIN ANTAGONISTS;

CAVIA PORCELLUS; GASTROPODA; STAPHYLOCOCCUS PHAGE 3A; SUS SCROFA;

EID: 0242362713     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.1081/RRS-120025568     Document Type: Article

References (35)

1. 3 receptor antagonists. Drugs 1997; 53:20-39.
2. Unwin N. Acetylcholine receptor channel imaged in the open state. Nature 1995; 373:37-43.
3. 3 receptor using site directed mutagenesis: importance of glutamate 106. Neuropharmacol 1997; 36:637-647.
4. Corringer PJ, Le Novere N, Changeux JP. Nicotinic receptors at the amino acid level. Annu Rev Pharmacol Toxicol 2002; 40:431-458.
5. 3 receptor, a serotonin-gated ion channel. Science 1991; 254:432-437.
6. S receptor subunit. Mol Pharmacol 1995; 48:1054-1062.
7. 3 receptor cDNA and its splice variants from guinea pig. Mol Pharmacol 1998; 53:202-212.
8. 3B subunit is a major determinant of serotonin-receptor function. Nature 1999; 397:359-363.
9. 3 receptor. J Biol Chem 1999; 274:5537-5541.
10. 3A receptor. Mol Pharmacol 2000; 57:1249-1255.
11. 3 receptor ligand binding domain. J Biol Chem 2000; 275:5620-5625.
12. 3A) and nicotinic acetylcholine receptors: The anomalous binding properties of nicotine. Biochemistry 2002; 41:10262-10269.
13. 3ASR binding. BMC Biochemistry 2002; 3:15.
14. 3A receptor subunits. Mol Pharmacol 1999; 55:1037-1043.
15. 3 and nACh ionotropic receptors: a perspective from the computational chemistry point of view. Curr Medicinal Chem 2002; 9:99-125.
16. 3 receptor extracellular domain: search for ligand binding sites. Theor Chim Acc 2001; 106:98-104.
17. Brejc K, Van Dijk W, Klaassen RV, Schuurmans M, Van der Oost J, Smit AB, Sixma TK. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 2001; 411:269-276.
18. 2+-binding sites. Proc Natl Acad Sci USA 2002; 99:3210-3214.25.
19. Sine SM, Wang HL, Bren N. Lysine scanning mutagenesis delineates structural model of the nicotinic receptor ligand binding domain. J Biol Chem 2002; 277:29210-29223.
20. Sullivan D, Chiara DC, Cohen JB. Mapping the agonist binding site of the nicotinic acetylcholine receptor by cysteine scanning mutagenesis: antagonist footprint and secondary structure prediction. Mol Pharmacol 2002; 61:463-472.
21. A receptor structure relieved by AChBP. Trends Biochem Sci 2002; 27: 280-287.
22. A α1β3γ2 receptors determined by molecular modeling. Biochim Biophys Acta 2002; 1565:91-96.
23. Laube B, Maksay G, Schemm R, Betz H. Modulation of glycine receptor activity: a novel approach for the therapeutic intervention at inhibitory synapses? Trends Pharmacol Sci 2002; 23:519-527.
24. Kelley LA, MacCallum RM, Sternberg MJE. Enhanced genome annotation using structural profiles in the program 3D-PSSM. J Mol Biol 2000; 299:501-522.
25. Bower M, Cohen FE, Dunbrack RL Jr. Sidechain prediction from a backbone-dependent rotamer library: a new tool for homology modeling. J Mol Biol 1997; 267:1268-1282.
26. Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Cryst 1993; 26:283-291.
27. McDonald IK, Thornton JM. Satisfying hydrogen bonding potential in proteins. J Mol Biol 1994; 238:777-793.
28. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ. Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function. J Comput Chem 1998; 19:1639-1662.
29. Cornell WD, Cieplak P, Bayly CI, Gould IR, Merz KM Jr, Ferguson DM, Spellmeyer DC, Fox T, Caldwell JW, Kollman PA. A second generation force field for the simulation of proteins, nucleic acids and organic molecules. J Am Chem Soc 1995; 117:5179-5197.
30. Russell RB, Saqi MA, Sayle RA, Bates PA, Sternberg MJE. Recognition of analogous and homologous protein folds: analysis of sequence and structure conservation. J Mol Biol 1997; 269:423-439.
31. Unwin N, Miyazawa A, Li J, Fujiyoshi Y. Activation of the nicotinic acetylcholine receptor involves a switch in conformation of the α subunits. J Mol Biol 2002; 319:1165-1176.
32. 3 receptor studied with a novel fluorescent ligand. Biochemistry 1998; 37:15850-15864.
33. 3 receptor. Neuropharmacol 1998; 37:251-257.
34. 3 receptor: the role of glutamate residues 97, 224, and 235. J Biol Chem 2003; 278:22709-22716.
35. 3 receptor agonist-binding residues using homology modeling. Biophysical J 2003; 84:2338-2344.